HANNA FRANCIS: Open Payments
NPI 1053021808 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,004 in 73 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $1,996 · 2025 $2,004
Food & beverage: $2,004
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 23 | $416 |
| AstraZeneca Pharmaceuticals LP | 8 | $265 |
| Actelion Pharmaceuticals US, Inc. | 3 | $205 |
| Grifols USA, LLC | 2 | $154 |
| Amgen Inc. | 2 | $151 |
| Verona Pharma, Inc. | 11 | $142 |
| Merck Sharp & Dohme LLC | 1 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $110 |
| United Therapeutics Corporation | 3 | $90 |
| Vifor Pharma, Inc. | 3 | $88 |
Products named: NUCALA, UPTRAVI, BREZTRI, Prolastin-C Liquid, TEZSPIRE, Ohtuvayre, TRELEGY ELLIPTA, ZERBAXA.
Industry payments across FL — which companies pay providers there.
